Literature DB >> 24709272

Diet and psoriasis, part I: Impact of weight loss interventions.

Maya Debbaneh1, Jillian W Millsop2, Bhavnit K Bhatia3, John Koo4, Wilson Liao4.   

Abstract

One of the most frequently asked questions by patients with psoriasis is whether dietary changes can improve their condition. Included in this discussion is whether dietary weight loss can benefit their skin disease. Obesity has been associated with a proinflammatory state and several studies have demonstrated a relationship between body mass index and psoriasis severity. However, the question of whether weight loss interventions can impact psoriasis outcome is less clear. Here, we review the literature to examine the efficacy of weight loss interventions, both dietary and surgical, on psoriasis disease course.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  body mass index; diet; gastric bypass; nutrition; obesity; psoriasis; weight loss

Mesh:

Year:  2014        PMID: 24709272      PMCID: PMC4065614          DOI: 10.1016/j.jaad.2014.02.012

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  39 in total

1.  Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease.

Authors:  V M Salvati; T T MacDonald; M Bajaj-Elliott; M Borrelli; A Staiano; S Auricchio; R Troncone; G Monteleone
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Gastric bypass surgery improves psoriasis.

Authors:  Eric W Hossler; Michele S Maroon; Chris M Mowad
Journal:  J Am Acad Dermatol       Date:  2010-07-22       Impact factor: 11.527

3.  Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.

Authors:  Alan Menter; Kenneth B Gordon; Craig L Leonardi; Yihua Gu; Orin M Goldblum
Journal:  J Am Acad Dermatol       Date:  2010-06-03       Impact factor: 11.527

4.  Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients.

Authors:  M M Farias; P Achurra; C Boza; A Vega; C de la Cruz
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

5.  Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

Authors:  J Koo
Journal:  Dermatol Clin       Date:  1996-07       Impact factor: 3.478

6.  Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.

Authors:  R J B Driessen; J B Boezeman; P C M van de Kerkhof; E M G J de Jong
Journal:  Br J Dermatol       Date:  2008-01-28       Impact factor: 9.302

7.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Authors:  Kim A Papp; Richard G Langley; Mark Lebwohl; Gerald G Krueger; Philippe Szapary; Newman Yeilding; Cynthia Guzzo; Ming-Chun Hsu; Yuhua Wang; Shu Li; Lisa T Dooley; Kristian Reich
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

8.  Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE data.

Authors:  N Cassano; A Galluccio; C De Simone; F Loconsole; S D Massimino; A Plumari; S Dattola; A Puglisi Guerra; L Donato; F Cantoresi; O De Pita; G Fenizi; V Altamura; M Congedo; R Pellicano; G A Vena
Journal:  J Biol Regul Homeost Agents       Date:  2008 Oct-Dec       Impact factor: 1.711

9.  Obesity and the risk of psoriatic arthritis: a population-based study.

Authors:  Thorvardur Jon Love; Yanyan Zhu; Yuqing Zhang; Lindsay Wall-Burns; Alexis Ogdie; Joel M Gelfand; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-05-14       Impact factor: 19.103

10.  Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis.

Authors:  M Esposito; A Mazzotta; R Saraceno; C Schipani; S Chimenti
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Jan-Mar       Impact factor: 3.219

View more
  18 in total

1.  Bariatric Surgery in Immunocompromised Patients: Outcomes from One Year Follow-up.

Authors:  Manish Khaitan; Aparna Hegde; P D Rekha
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

2.  Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.

Authors:  Alanna C Bridgman; Abrar A Qureshi; Tricia Li; Fred K Tabung; Eunyoung Cho; Aaron M Drucker
Journal:  J Am Acad Dermatol       Date:  2019-02-21       Impact factor: 11.527

3.  Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.

Authors:  Juan Carlos Torre-Alonso; Loreto Carmona; Mireia Moreno; Eva Galíndez; Jesús Babío; Pedro Zarco; Luis Linares; Eduardo Collantes-Estevez; Manuel Fernández Barrial; Juan Carlos Hermosa; Pablo Coto; Carmen Suárez; Raquel Almodóvar; Jesús Luelmo; Santos Castañeda; Jordi Gratacós
Journal:  Rheumatol Int       Date:  2017-04-07       Impact factor: 2.631

4.  Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer.

Authors:  Sebastian Yu; Xuesong Wu; Zhenrui Shi; Mindy Huynh; Prasant Kumar Jena; Lili Sheng; Yan Zhou; Dan Han; Yu-Jui Yvonne Wan; Samuel T Hwang
Journal:  J Dermatol Sci       Date:  2020-01-24       Impact factor: 4.563

5.  Lifestyle changes for treating psoriasis.

Authors:  Shu-Hua Ko; Ching-Chi Chi; Mei-Ling Yeh; Shu-Hui Wang; Yu-Shiun Tsai; Mei-Ya Hsu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16

6.  Impact of Bariatric Surgery on Hidradenitis Suppurativa.

Authors:  Clothilde Canard; Ana Diaz Cives; Isabelle Gaubil-Kaladjian; Eric Bertin; Manuelle Viguier
Journal:  Acta Derm Venereol       Date:  2021-06-02       Impact factor: 3.875

7.  Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?

Authors:  Luigi Barrea; Nicola Balato; Carolina Di Somma; Paolo Emidio Macchia; Maddalena Napolitano; Maria Cristina Savanelli; Katherine Esposito; Annamaria Colao; Silvia Savastano
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

8.  Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response.

Authors:  Zuzana Zákostelská; Jana Málková; Klára Klimešová; Pavel Rossmann; Michaela Hornová; Iva Novosádová; Zuzana Stehlíková; Martin Kostovčík; Tomáš Hudcovic; Renata Štepánková; Kateřina Jůzlová; Jana Hercogová; Helena Tlaskalová-Hogenová; Miloslav Kverka
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

9.  Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey.

Authors:  Ladan Afifi; Melissa J Danesh; Kristina M Lee; Kevin Beroukhim; Benjamin Farahnik; Richard S Ahn; Di Yan; Rasnik K Singh; Mio Nakamura; John Koo; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2017-05-19

Review 10.  Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist.

Authors:  Luigi Barrea; Francesca Nappi; Carolina Di Somma; Maria Cristina Savanelli; Andrea Falco; Anna Balato; Nicola Balato; Silvia Savastano
Journal:  Int J Environ Res Public Health       Date:  2016-07-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.